Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Cantor Fitzgerald
US Department of Justice
Boehringer Ingelheim

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,703,038

« Back to Dashboard

Summary for Patent: 4,703,038

Title: Combination of dihydropyridines with angiotensin converting enzymes-inhibitors
Abstract:The invention concerns a combination of dihydropyridine derivatives with compounds which inhibit the formation of enzymes which control the conversion of angiotensin I into angiotensin II and their use as antihypertensive agents.
Inventor(s): Garthoff; Bernward (Hilden, DE), Kazda; Stanislav (Wuppertal, DE), Knorr; Andreas (Wuppertal, DE)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:06/785,182
Patent Claim Types:
see list of patent claims
Compound; Use; Process;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,703,038

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3437917Oct 17, 1984

International Patent Family for Patent: 4,703,038

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria44650► Subscribe
Australia4840085► Subscribe
Canada1251733► Subscribe
German Democratic Republic239525► Subscribe
Germany3437917► Subscribe
Germany3571550► Subscribe
Denmark473585► Subscribe
European Patent Office0180785► Subscribe
Spain547931► Subscribe
Spain8703089► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus